The HPV Vaccine Prevents Cancer
In the U.S., HPV infections are estimated to cause about 37,300 cases of cancer. The HPV vaccine can prevent over 90% of these cancers from ever developing.
A new study has found a dramatic drop in the rates of cervical pre-cancers among young adult women. This is great news and further proof that the HPV vaccine is working.
HPV is a group of over 100 different types of viruses. Some types of HPV can cause genital warts and other types—referred to as high risk types—can cause cancer of the cervix, vulva, vagina, penis or anus, as well as cancer in the back of the throat. The HPV vaccine protects against nine types of HPV associated with genital warts and cancer.
We already know that the vaccine is working. Infections with the types of HPV that are most likely to cause cancers and genital warts have dropped by 88 percent in teen girls and 81 percent in young women. We also know that cervical cancer rates have been dropping since the introduction of the vaccine. Rates for women ages 20 to 24 declined 11% each year between 2012 and 2019. This is the age group most likely to have gotten the vaccine before they were sexually active.
The new study looks at cervical pre-cancers. Cervical cancer develops gradually as cells experience abnormal changes. These changes can be detected through a Pap test—also referred to as cytology—where samples of cells from the cervix are collected and examined under a microscope. These tests can detect abnormal cell changes, sometimes called cervical dysplasia, long before they become cancer, and treatments can’t prevent cancer from ever forming. This is why screening is so important.
Pre-cancers are classified by severity or likelihood of become cancer:
The new study found that rates of CIN2 and CIN3 have fallen dramatically especially among the youngest women. Between 2008 and 2022, rates of CIN2 pre-cancers fell 79% among young women who were 20 to 24 at the end of the study period. During that same time rates of CIN3 pre-cancers among this group fell 80%. Rates also dropped among older women. Those who were 25-29 in 2022 saw a 37% drop in CIN3 pre-cancers. The HPV vaccine was approved in 2006, meaning it would have been available when most of these women turned 11 or soon after.
In contrast, pre-cancer rates rose among women who were 40-49 and 50-64 in 2022. These women would have been between 24 and 48 when the vaccine was first introduced, and thus many of them missed the window for vaccination. If they were vaccinated, it was likely after they’d become sexually active.
The study was published in the CDC’s Morbidity and Mortality Weekly Report. The authors conclude, “These data are consistent with considerable impact of HPV vaccination for preventing cervical precancers among women in the age groups most likely to have been vaccinated and support existing recommendations to vaccinate children at the routinely recommended ages as a cancer prevention measure.”
At a time when anti-vaccine sentiment is high, results like these can remind us why vaccinations are so important. This study adds to information we already had showing that the HPV vaccine is successfully preventing cancer.
In the U.S., HPV infections are estimated to cause about 37,300 cases of cancer. The HPV vaccine can prevent over 90% of these cancers from ever developing.
Though usually harmless, some types of HPV cause cervical lesions that, over a period of time, can develop into cancer if untreated.
There’s a new way to screen for cervical cancer—no pelvic exam, stirrups, or speculum involved.
In the U.S., HPV infections are estimated to cause about 37,300 cases of cancer. The HPV vaccine can prevent over 90% of these cancers from ever developing.
Though usually harmless, some types of HPV cause cervical lesions that, over a period of time, can develop into cancer if untreated.
There’s a new way to screen for cervical cancer—no pelvic exam, stirrups, or speculum involved.
In the U.S., HPV infections are estimated to cause about 37,300 cases of cancer. The HPV vaccine can prevent over 90% of these cancers from ever developing.
Though usually harmless, some types of HPV cause cervical lesions that, over a period of time, can develop into cancer if untreated.
There’s a new way to screen for cervical cancer—no pelvic exam, stirrups, or speculum involved.
You have probably heard that HPV can cause cervical cancer. But did you know that it can also cause cancers of the mouth, tongue, and throat?
The American Cancer Society estimates that there will be about 11,270 new cases of anal cancer in the U.S. in 2026, with approximately 1,700 deaths.
A new study revealed a disturbing trend in health knowledge; fewer people seem to understand the connection between HPV and certain types of cancer including cervical, oral, anal, and penile cancers.
Read stories from three men on their personal experiences with HPV-related cancer.
You have probably heard that HPV can cause cervical cancer. But did you know that it can also cause cancers of the mouth, tongue, and throat?
The American Cancer Society estimates that there will be about 11,270 new cases of anal cancer in the U.S. in 2026, with approximately 1,700 deaths.
A new study revealed a disturbing trend in health knowledge; fewer people seem to understand the connection between HPV and certain types of cancer including cervical, oral, anal, and penile cancers.
Read stories from three men on their personal experiences with HPV-related cancer.
You have probably heard that HPV can cause cervical cancer. But did you know that it can also cause cancers of the mouth, tongue, and throat?
The American Cancer Society estimates that there will be about 11,270 new cases of anal cancer in the U.S. in 2026, with approximately 1,700 deaths.
A new study revealed a disturbing trend in health knowledge; fewer people seem to understand the connection between HPV and certain types of cancer including cervical, oral, anal, and penile cancers.
Read stories from three men on their personal experiences with HPV-related cancer.
ASHA believes that all people have the right to the information and services that will help them to have optimum sexual health. We envision a time when stigma is no longer associated with sexual health and our nation is united in its belief that sexuality is a normal, healthy, and positive aspect of human life.
ABOUT
GET INVOLVED
ASHA WEBSITES
GET HELP
© 2026 American Sexual Health Association
We need to know if we can keep you company during this visit. We are useful for making this site work.